US6429207B1
(en)
|
1997-11-21 |
2002-08-06 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
EP1408980A4
(fr)
|
2001-06-21 |
2004-10-20 |
Ariad Pharma Inc |
Nouvelles quinazolines et leur utilisation
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
US6924285B2
(en)
|
2002-03-30 |
2005-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. |
Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
|
WO2003104230A1
(fr)
|
2002-06-07 |
2003-12-18 |
協和醱酵工業株式会社 |
Derives bicycliques de pyrimidine
|
US7423044B2
(en)
|
2002-09-05 |
2008-09-09 |
Wyeth |
Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemia
|
AR044743A1
(es)
*
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
|
US7196106B2
(en)
|
2002-11-05 |
2007-03-27 |
Merck & Co., Inc |
Cyanothiophene derivatives, compositions containing such compounds and methods of use
|
KR100772297B1
(ko)
*
|
2002-11-22 |
2007-11-02 |
니뽄 다바코 산교 가부시키가이샤 |
융합 비시클릭 질소-함유 헤테로사이클
|
US7759336B2
(en)
*
|
2002-12-10 |
2010-07-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
MXPA05011103A
(es)
|
2003-04-16 |
2005-12-12 |
Hoffmann La Roche |
Compuestos de quinazolina.
|
CN1774250A
(zh)
|
2003-04-16 |
2006-05-17 |
霍夫曼-拉罗奇有限公司 |
作为治疗诸如类风湿性关节炎的炎性疾病的p38激酶抑制剂的(6-(苯氧基)-吡啶并[3,4-d]嘧啶-2-基)-胺衍生物
|
JP2007501801A
(ja)
|
2003-08-07 |
2007-02-01 |
日本たばこ産業株式会社 |
ピロロ[1,2−b]ピリダジン誘導体
|
WO2005016925A1
(fr)
*
|
2003-08-14 |
2005-02-24 |
Pfizer Limited |
Derives d'azaquinazoline
|
TW200530235A
(en)
|
2003-12-24 |
2005-09-16 |
Renovis Inc |
Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
|
JPWO2005085210A1
(ja)
*
|
2004-03-10 |
2008-01-17 |
小野薬品工業株式会社 |
ニトリル化合物およびその化合物を有効成分として含有する医薬組成物
|
US7793137B2
(en)
|
2004-10-07 |
2010-09-07 |
Cisco Technology, Inc. |
Redundant power and data in a wired data telecommunincations network
|
US7598259B2
(en)
|
2004-06-15 |
2009-10-06 |
Schering Corporation |
mGluR1 antagonists as therapeutic agents
|
PE20060526A1
(es)
*
|
2004-06-15 |
2006-07-13 |
Schering Corp |
Compuestos triciclicos como antagonistas de mglur1
|
AU2005290226A1
(en)
|
2004-07-16 |
2006-04-06 |
Sunesis Pharmaceuticals, Inc. |
Thienopyrimidines useful as Aurora kinase inhibitors
|
US7928107B2
(en)
|
2004-09-02 |
2011-04-19 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
US8283354B2
(en)
|
2004-09-02 |
2012-10-09 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
NZ589252A
(en)
*
|
2004-09-02 |
2012-06-29 |
Vertex Pharma |
Quinazolines useful as inhibitors of voltage-gated sodium channels
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
GB0420719D0
(en)
*
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
US20060128710A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Chih-Hung Lee |
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
|
US7402596B2
(en)
|
2005-03-24 |
2008-07-22 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
CA2606760C
(fr)
|
2005-05-04 |
2014-12-23 |
Renovis, Inc. |
Composes de tetrahydronaphthyridine et de tetrahydropyrido[4,3-d]pyrimidine et compositions de ceux-ci utiles dans lediraitement des conditions associees aux troubles et dysfonctions neurologiques et inflammatoires
|
US7825244B2
(en)
|
2005-06-10 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
|
US8071768B2
(en)
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
CN101277939A
(zh)
*
|
2005-09-09 |
2008-10-01 |
布里斯托尔-迈尔斯斯奎布公司 |
无环ikur抑制剂
|
WO2007070872A1
(fr)
|
2005-12-15 |
2007-06-21 |
Rigel Pharmaceuticals, Inc. |
Inhibiteurs de kinase et leurs utilisations
|
HUP0501168A3
(en)
*
|
2005-12-20 |
2007-10-29 |
Richter Gedeon Nyrt |
2-(acyl, oxycarbonyl or aminocarbonyl)-3-phenyl-thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical composition containing them
|
HUP0501170A2
(en)
*
|
2005-12-20 |
2007-09-28 |
Richter Gedeon Nyrt |
2-heteroaryl-3-phenyl-thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical compositions containing them
|
CA2630896A1
(fr)
*
|
2005-12-20 |
2007-06-28 |
Richter Gedeon Nyrt. |
Nouveaux composes
|
ATE479690T1
(de)
*
|
2005-12-20 |
2010-09-15 |
Richter Gedeon Nyrt |
Thienoä2,3-büpyridin derivate
|
EP1971611B1
(fr)
|
2005-12-21 |
2012-10-10 |
Abbott Laboratories |
Composes anti-viraux
|
WO2007076034A2
(fr)
|
2005-12-21 |
2007-07-05 |
Abbott Laboratories |
Composes antiviraux
|
CN102702194A
(zh)
|
2005-12-21 |
2012-10-03 |
雅培制药有限公司 |
抗病毒化合物
|
EP2345652A1
(fr)
|
2005-12-21 |
2011-07-20 |
Abbott Laboratories |
Composées antivirales
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
DE102006012251A1
(de)
*
|
2006-03-15 |
2007-11-08 |
Grünenthal GmbH |
Substituierte 4-Amino-chinazolin-Derivate und ihre Verwendung zur Herstellung von Arzneimitteln
|
EP1921070A1
(fr)
|
2006-11-10 |
2008-05-14 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
heterocycles bicycliques, medicaments á base de ces composes, leur usage et procédé pour leur preparation
|
JP2010510314A
(ja)
|
2006-11-22 |
2010-04-02 |
シーサイド セラピューティクス,エルエルシー |
精神遅滞、ダウン症候群、脆弱x症候群および自閉症の治療方法
|
CA2672737A1
(fr)
|
2006-12-20 |
2008-11-06 |
Abbott Laboratories |
Composes antiviraux
|
EP2118075A1
(fr)
|
2007-02-06 |
2009-11-18 |
Boehringer Ingelheim International GmbH |
Hétérocycles bicycliques, agents pharmaceutiques contenant ces composés, leur utilisation et leur procédé de préparation
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
WO2008157500A1
(fr)
*
|
2007-06-17 |
2008-12-24 |
Kalypsys, Inc. |
Modulateurs du récepteur cannabinoïde à base d'aminoquinazoline pour le traitement de maladies
|
NZ582934A
(en)
|
2007-08-02 |
2011-10-28 |
Recordati Ireland Ltd |
Novel heterocyclic compounds as mglu5 antagonists
|
TW200922566A
(en)
|
2007-09-14 |
2009-06-01 |
Ortho Mcneil Janssen Pharm |
1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
|
ES2356032T3
(es)
|
2007-09-14 |
2011-04-04 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
4-fenil-3,4,5,6-tetrahidro-2h,1'h-[1,4']bipiridinil-2'-onas 1,3'-disustituidas.
|
JP5336516B2
(ja)
|
2008-02-07 |
2013-11-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
スピロ環式複素環化合物、該化合物を含む医薬品、その使用及びその製造方法
|
ES2444128T3
(es)
|
2008-05-13 |
2014-02-24 |
Astrazeneca Ab |
Nueva SAL-554
|
US8648191B2
(en)
|
2008-08-08 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
|
MX2011002042A
(es)
|
2008-09-02 |
2011-06-20 |
Ortho Mcneil Janssen Pharm |
Derivados de 3-azabiciclo[3.1.o]hexilo como moduladores de los receptores del glutamato metabotropico.
|
US8759362B2
(en)
*
|
2008-10-24 |
2014-06-24 |
Purdue Pharma L.P. |
Bicycloheteroaryl compounds and their use as TRPV1 ligands
|
CA2744343A1
(fr)
*
|
2008-11-19 |
2010-05-27 |
Renovis, Inc. |
Composes 6, 7 -dihydro- 5h- pyrrolo [3, 4-d] pyrimidin-4-yl] -quinolin-3 -ylamine s'utilisant comme modulateurs de la faah et utilisations desdits composes
|
EP2373649B1
(fr)
|
2008-11-28 |
2013-01-23 |
Janssen Pharmaceuticals, Inc. |
Dérivés d'indole et de benzoxazine comme modulateurs des récepteurs métabotropiques au glutamate
|
SG172060A1
(en)
*
|
2008-12-09 |
2011-07-28 |
Gilead Sciences Inc |
Modulators of toll-like receptors
|
EP2393780A1
(fr)
|
2009-02-04 |
2011-12-14 |
Recordati Ireland Limited |
Dérivés hétérocycliques en tant qu'antagonistes de mglu5
|
NZ596053A
(en)
|
2009-05-12 |
2013-05-31 |
Janssen Pharmaceuticals Inc |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
MX2011011964A
(es)
|
2009-05-12 |
2012-02-23 |
Janssen Pharmaceuticals Inc |
Derivados de 1,2,3-triazolo[4,3-a]piridina y su uso para el tratamiento o prevencion de trastornos neurologicos y psiquiatricos.
|
WO2011029633A1
(fr)
|
2009-09-14 |
2011-03-17 |
Recordati Ireland Limited |
Antagonistes hétérocycliques de mglu5
|
WO2011106276A1
(fr)
*
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Antagonistes des canaux task
|
US20130058915A1
(en)
|
2010-03-02 |
2013-03-07 |
Children's Medica Center Corporation |
Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
|
US20110294879A1
(en)
|
2010-05-28 |
2011-12-01 |
Xenoport, Inc. |
Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
|
KR101862626B1
(ko)
*
|
2010-07-09 |
2018-05-31 |
레코르다티 아일랜드 리미티드 |
Mglu5 대항체로서의 신 스피로헤테로사이클릭 화합물
|
US20120016021A1
(en)
|
2010-07-15 |
2012-01-19 |
Xenoport, Inc. |
Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
|
US8551981B2
(en)
|
2010-10-08 |
2013-10-08 |
Abbvie Inc. |
Furo[3,2-d]pyrimidine compounds
|
WO2012054724A1
(fr)
|
2010-10-21 |
2012-04-26 |
Massachusetts Institute Of Technology |
Méthodes de traitement de troubles épileptiques
|
EP2649069B1
(fr)
|
2010-11-08 |
2015-08-26 |
Janssen Pharmaceuticals, Inc. |
Dérivés de 1,2,4-triazolo[4,3-a]pyridine et leur utilisation en tant que modulateurs allostériques positifs des récepteurs mglur2
|
US9012448B2
(en)
|
2010-11-08 |
2015-04-21 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
US9464089B2
(en)
|
2012-01-13 |
2016-10-11 |
Acea Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
US9586965B2
(en)
|
2012-01-13 |
2017-03-07 |
Acea Biosciences Inc. |
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
|
US9034885B2
(en)
|
2012-01-13 |
2015-05-19 |
Acea Biosciences Inc. |
EGFR modulators and uses thereof
|
JP6353788B2
(ja)
|
2012-01-13 |
2018-07-04 |
エイシア バイオサイエンシーズ インコーポレイテッド |
抗がん剤としての複素環式化合物およびその使用
|
TWI499591B
(zh)
|
2013-01-11 |
2015-09-11 |
Lilly Co Eli |
雙環嘧啶化合物
|
TW201520219A
(zh)
|
2013-03-12 |
2015-06-01 |
Lilly Co Eli |
咪唑並吡啶化合物
|
TW201500356A
(zh)
*
|
2013-04-12 |
2015-01-01 |
Lilly Co Eli |
二氫吡啶并嘧啶化合物
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
EP3019496B1
(fr)
|
2013-07-11 |
2019-09-11 |
ACEA Therapeutics, Inc. |
Dérivés de la pyrimidine comme inhibiteurs des kinases.
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
KR102414246B1
(ko)
|
2014-01-21 |
2022-06-27 |
얀센 파마슈티카 엔.브이. |
대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
|
LT3431106T
(lt)
|
2014-01-21 |
2021-02-10 |
Janssen Pharmaceutica Nv |
Deriniai, apimantys 2 potipio metabotropinio glutamaterginio receptoriaus teigiamus alosterinius moduliatorius arba ortosterinius agonistus, ir jų panaudojimas
|
US9868744B2
(en)
|
2014-04-25 |
2018-01-16 |
Pfizer Inc. |
Heteroaromatic compounds and their use as dopamine D1 ligands
|
CN108290855A
(zh)
|
2015-07-01 |
2018-07-17 |
西北大学 |
被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途
|
EP3325490B1
(fr)
|
2015-07-23 |
2019-12-18 |
Takeda Pharmaceutical Company Limited |
DÉRIVÉS DE 1,2,3,4-TÉTRAHYDRO-1,7-NAPHTYRIDIN-8-AMINE SUBSTITUÉS EN POSITION 1
ET LEUR UTILISATION EN TANT QU ANTAGONISTES DU RÉCEPTEUR EP4
|
US10533011B2
(en)
|
2015-10-09 |
2020-01-14 |
ACEA Therapeutics, Inc. |
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
|
GB201700814D0
(en)
*
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
BR112019020840A2
(pt)
|
2017-04-07 |
2020-04-28 |
Acea Therapeutics Inc |
sais farmacêuticos, formas físicas e composições de inibidores da pirrolopirimidina quinase e métodos de produção dos mesmos
|
US11919833B2
(en)
*
|
2021-04-26 |
2024-03-05 |
Mitsubishi Gas Chemical Company, Inc. |
Compound and method for producing same
|